| 1. |
L?nnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol, 2014, 2(9): 730-739.
|
| 2. |
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12): 1090-1101.
|
| 3. |
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008, 5(7): e152.
|
| 4. |
鄒立群, 徐愛暉. 肺結核病合并2型糖尿病患者臨床特征分析. 臨床肺科雜志, 2008, 5(7): e152-526.
|
| 5. |
Kuo MC, Lin SH, Lin CH, et al. Type 2 diabetes: an independent risk factor for tuberculosis: a nationwide population-based study. PloS One, 2013, 8(11): e78924.
|
| 6. |
蔡娜. 天津市海河醫院結核合并2型糖尿病病例資料流行病學分析. 中國慢性病預防與控制, 2012, 20(1): 65-67.
|
| 7. |
Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology, 2021, S0161-6420(21): 00321-3.
|
| 8. |
Lin Y, Yuan Y, Zhao X, et al. The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China. Glob Health Action, 2017, 10(1): 1289737.
|
| 9. |
Saeedi P, Salpea P, Karuranga S, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas, 9th edition. Dibetes Res Clin Pract, 2020: 108086.
|
| 10. |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. (2020-10-14)[2021-07-28].https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
|
| 11. |
World Health Organization. Global tuberculosis control 2017. Geneva: World Health Organization, 2017. (2017-11-08)[2021-09-27].https://www.polity.org.za/article/global-tuberculosis-report-2017-2017-11-08.
|
| 12. |
Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health, 2019, 7(4): e448-e460.
|
| 13. |
Restrepo BI, Fisher-Hoch SP, Pino PA, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis, 2008, 47(5): 634-641.
|
| 14. |
Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011: 81.
|
| 15. |
Faurholt-Jepsen D, Range N, PrayGod G, et al. The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Trop Med Int Health, 2012, 17(7): 877-883.
|
| 16. |
Bailey SL, Grant P. ‘The tubercular diabetic’: the impact of diabetes mellitus on tuberculosis and its threat to global tuberculosis control. Clin Med(Lond), 2011, 11(4): 344-347.
|
| 17. |
Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep, 2017, 7(1): 1090.
|
| 18. |
Saktiawati AMI, Subronto YW. Influence of diabetes mellitus on the development of multi drug resistant-tuberculosis in Yogyakarta. Acta Med Indones, 2018, 50(1): 11-17.
|
| 19. |
全國第五次結核病流行病學抽樣調查技術指導組, 全國第五次結核病流行病學抽樣調查辦公室. 2010 年全國第五次結核病流行病學抽樣調查報告. 中國防癆雜志, 2012, 34(8): 485-508.
|
| 20. |
王蕓, 許琳, 邱玉冰, 等. 主動篩查方式下云南省6個偏遠農村肺結核患病情況分析. 現代預防醫學, 2014, 41(19): 3606-3608,3620.
|
| 21. |
王倪, 周林, 白麗瓊, 等. 新發涂陽肺結核患者就診和診斷延誤的影響因素研究. 中國防癆雜志, 2012, 34(12): 790-794.
|
| 22. |
Ruslami R, Aarnoutse RE, Alisjahbana B, et al. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health, 2010, 15(11): 1289-1299.
|
| 23. |
齊威, 李敬新, 傅衍勇, 等. 糖尿病對肺結核患者治療效果的影響. 中國慢性病預防與控制, 2015, 23(1): 54-56.
|
| 24. |
Cheng J, Zhang H, Zhao YL, et al. Mutual impact of diabetes mellitus and tuberculosis in China. Biomed Environ Sci, 2017, 30(5): 384-389.
|
| 25. |
杜昕, 黃飛, 陸偉, 等. 2010-2012年全國肺結核登記率變化趨勢分析. 中國防癆雜志, 2013, 35(5): 337-342.
|
| 26. |
瞿媛, 普麗, 蘇麗敏, 等. 玉溪市紅塔區重點人群肺結核主動篩查模式探究. 實用預防醫學, 2017, 24(8): 971-973.
|
| 27. |
王偉炳, 王法弟, 徐飚, 等. 經濟較發達農村地區結核病慢性咳嗽線索篩查的成本. 中華流行病學雜志, 2006, 27(10): 857-860.
|
| 28. |
中華人民共和國中央人民政府. 國務院辦公廳關于印發全國結核病防治規劃(2011—2015年)的通知. (2011-11-17) [2019-7-29]. http://www.gov.cn/zhengce/content/2011-12/06/content_6143.htm.
|
| 29. |
劉二勇, 周林, 成君, 等. 健康檢查與被動就診在肺結核患者發現中的對比研究. 中國防癆雜志, 2014, 36(5): 327-330.
|
| 30. |
胡嘉, 邱林西, 黃欽, 等. 貧困地區糖尿病患者中結核病檢出率及其影響因素分析. 預防醫學, 2016, 28(9): 913-915.
|
| 31. |
齊威, 傅衍勇, 徐瑛. 糖尿病對結核病的影響. 中國慢性病預防與控制, 2013, 21(2): 238-240.
|
| 32. |
熊昌富, 劉曉俊, 劉勛, 等. 采用綜合措施提高肺結核傳染源早期發現的研究. 公共衛生與預防醫學, 2011, 22(4): 46-49.
|
| 33. |
熊昌富, 周麗平, 張險峰, 等. 村醫集中推薦肺結核可疑癥狀者檢查對提高新涂陽肺結核發現率的研究. 中國防癆雜志, 2006, 28(6): 370-372.
|
| 34. |
Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012, 17(10): 1302-1308.
|
| 35. |
World Health Organization. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization, 2012.
|
| 36. |
彭紅, 許衛國, 翟祥軍, 等. 江蘇農村社區一般人群胸部X線攝片主動篩查肺結核的效果評估. 中國防癆雜志, 2014, 36(12): 1029-1034.
|
| 37. |
張燦有. 肺結核患者不同發現策略的成本效果研究. 北京: 中國疾病預防控制中心, 2013.
|
| 38. |
成君, 張燦有, 陳卉, 等. 采取因地制宜的措施加強重點人群結核病防控. 中國防癆雜志, 2021, 43(3): 217-221.
|
| 39. |
World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: Worder Health Organization, 2013.
|
| 40. |
中華人民共和國國家衛生健康委員會. 國家衛生計生委關于印發《國家基本公共衛生服務規范(第三版) 》的通知. (2017-02-28)[2019-10-15]. http://www.nhc.gov.cn/jws/s3578/201703/d20c37e23e1f4c7db7b8e25f34473e1b.shtml.
|
| 41. |
趙文靜. 我國糖尿病患者中結核病病例主動發現策略的經濟學評價研究. 濟南: 山東大學, 2014.
|